Literature DB >> 24542412

Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse.

D E EYLES, N COLEMAN.   

Abstract

Entities:  

Keywords:  PYRIMIDINES/effects; SULFADIAZINE/effects; TOXOPLASMOSIS/experimental

Mesh:

Substances:

Year:  1953        PMID: 24542412

Source DB:  PubMed          Journal:  Antibiot Chemother (Northfield)        ISSN: 0570-3123


× No keyword cloud information.
  12 in total

1.  [Toxoplasmosis lymphadenitis: clinical picture, cytology of lymph node punctate, treatment].

Authors:  H J KABELITZ
Journal:  Klin Wochenschr       Date:  1958-06-01

Review 2.  Toxoplasmosis: A history of clinical observations.

Authors:  Louis M Weiss; Jitender P Dubey
Journal:  Int J Parasitol       Date:  2009-02-13       Impact factor: 3.981

3.  [Electron-microscopical findings in aureomycin therapy of toxoplasmosis].

Authors:  J HOLZ; G BRINGMANN
Journal:  Z Hyg Infektionskr       Date:  1954

4.  Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design.

Authors:  Matthew E Welsch; Jian Zhou; Yueqiang Gao; Yunqing Yan; Gene Porter; Gautam Agnihotri; Yingjie Li; Henry Lu; Zhongguo Chen; Stephen B Thomas
Journal:  ACS Med Chem Lett       Date:  2016-09-17       Impact factor: 4.345

5.  Rebound of cyst number following discontinuation of guanabenz treatment for latent toxoplasmosis.

Authors:  Jennifer Martynowicz; William J Sullivan
Journal:  Mol Biochem Parasitol       Date:  2021-09-04       Impact factor: 1.845

6.  In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.

Authors:  F G Araujo; R M Shepard; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

Review 7.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

Review 8.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

Review 9.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

10.  Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function.

Authors:  Robert A Charvat; Gustavo Arrizabalaga
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.